1
|
Yu S, Zhou X, Liu R, Xu X, Ma D, Feng Y, Lin X. Immunomodulatory Effects of Yu-Ping-Feng Formula on Primary Sjögren's Syndrome: Interrogating the T Cell Response. J Leukoc Biol 2024:qiae155. [PMID: 38953166 DOI: 10.1093/jleuko/qiae155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2024] [Revised: 05/23/2024] [Accepted: 06/10/2024] [Indexed: 07/03/2024] Open
Abstract
Ethnopharmacological treatments have shown beneficial effects in the clinical practice of autoimmune disorders. However, the underlying mechanism of immunomodulatory effects remains challenging, given the complicate composition of herbal medicines. Here, we developed an immunological approach to interrogate the T helper cell response. Through data mining we hypothesized that Chinese medicine formula, Yu-Ping-Feng (YPF) might be a promising candidate for treating primary Sjögren's syndrome (pSS), a common autoimmune disease manifested by exocrine gland dysfunction. We took advantage of a mouse model of experimental Sjögren's syndrome (ESS) that we previously established for YPF formula treatment. YPF therapy ameliorated the ESS pathology in mice with active disease, showing improved salivary function and decreased serum levels of autoantibodies. Phenotypic analysis suggested that both effector T and B cells were significantly suppressed. Using co-culture assay and adoptive transfer models, we demonstrated that YPF formula directly restrained effector/memory T cell expansion and differentiation into Th17 and T follicular helper (Tfh) cells, the key subsets in ESS pathogenesis. Importantly, we recruited 20 pSS patients and conducted a pilot study of 8-week therapy of YPF formula. YPF treatment effectively improved fatigue symptoms, exocrine gland functions and reduced serum IgG/IgA levels, while effector T and B cell subsets were significantly decreased. There was a trend of reduction on disease activity, but not statistically significant. Together, our findings suggested a novel approach to assess the immunomodulatory effects of YPF formula, which may be favorable for patients with autoimmune disorders.
Collapse
Affiliation(s)
- Sulan Yu
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hon Kong SAR 999077, China
| | - Xinyao Zhou
- 2Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijng 100053, China
| | - Ruihua Liu
- 2Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijng 100053, China
| | - Xiaoyu Xu
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hon Kong SAR 999077, China
| | - Danbao Ma
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hon Kong SAR 999077, China
| | - Yun Feng
- Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China
| | - Xiang Lin
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hon Kong SAR 999077, China
- Department of Chinese Medicine, the University of Hong Kong-Shenzhen Hospital (HKU-SZH), Shenzhen 518053, China
| |
Collapse
|
2
|
Yu PJ, Zhou M, Liu Y, Du J. Senescent T Cells in Age-Related Diseases. Aging Dis 2024:AD.2024.0219. [PMID: 38502582 DOI: 10.14336/ad.2024.0219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Accepted: 02/18/2024] [Indexed: 03/21/2024] Open
Abstract
Age-induced alterations in human immunity are often considered deleterious and are referred to as immunosenescence. The immune system monitors the number of senescent cells in the body, while immunosenescence may represent the initiation of systemic aging. Immune cells, particularly T cells, are the most impacted and involved in age-related immune function deterioration, making older individuals more prone to different age-related diseases. T-cell senescence can impact the effectiveness of immunotherapies that rely on the immune system's function, including vaccines and adoptive T-cell therapies. The research and practice of using senescent T cells as therapeutic targets to intervene in age-related diseases are in their nascent stages. Therefore, in this review, we summarize recent related literature to investigate the characteristics of senescent T cells as well as their formation mechanisms, relationship with various aging-related diseases, and means of intervention. The primary objective of this article is to explore the prospects and possibilities of therapeutically targeting senescent T cells, serving as a valuable resource for the development of immunotherapy and treatment of age-related diseases.
Collapse
|
3
|
Matsushima M, Nose H, Tsuzuki H, Takekoshi M, Kusatsugu Y, Taniguchi H, Ohdachi T, Hashimoto N, Sato M, Kawabe T. Decrease in cholesterol in the cell membrane is essential for Nrf2 activation by quercetin. J Nutr Biochem 2023; 116:109329. [PMID: 36958420 DOI: 10.1016/j.jnutbio.2023.109329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2022] [Revised: 11/21/2022] [Accepted: 03/17/2023] [Indexed: 03/25/2023]
Abstract
Quercetin is a flavonoid with various cytoprotective effects. We previously reported that quercetin exerts anti-allergic, anti-oxidative, and anti-fibrotic activities via the induction of heme oxygenase (HO)-1. However, the mechanisms by which quercetin induces HO-1 to exhibit cytoprotective effects are poorly understood. We focused on its action on the cell membrane, which is the first part of the cell to interact with the extracellular environment. The cell membrane contains lipid rafts and caveolae, which play important roles in cellular signaling. A recent study showed that nuclear factor E2-related factor 2 (Nrf2), a transcription factor regulating anti-oxidative enzymes including HO-1, interacts with caveolin-1 (Cav-1), a component of caveolae, to regulate cellular anti-oxidative capacity. In this study, we investigated the changes in the cell membrane that leads to the induction of HO-1 by quercetin. Quercetin decreased the amount of cholesterol in the raft fractions, which in turn promoted the induction of HO-1. It also changed the composition of the lipid rafts and decreased and increased the expression of Cav-1 in the raft and non-raft fractions, respectively. Nrf2, which was localized in the cell membrane under resting conditions, was translocated along with Cav-1 to the nucleus after exposure to quercetin. These findings indicate for the first time that the HO-1-dependent cytoprotective effects of quercetin are mediated by the structural changes in lipid rafts brought about by decreasing the amount of cholesterol in the cell membrane, which thereby results in the translocation of the Cav-1-Nrf2 complex to the nucleus and induces the expression of HO-1.
Collapse
Affiliation(s)
- Miyoko Matsushima
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Haruka Nose
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Hikaru Tsuzuki
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Masahiro Takekoshi
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Yuto Kusatsugu
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Hinata Taniguchi
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Tomoko Ohdachi
- Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Naozumi Hashimoto
- Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Mitsuo Sato
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System
| | - Tsutomu Kawabe
- Division of Host Defense Sciences, Omics Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Tokai National Higher Education and Research System.
| |
Collapse
|
4
|
Miquelianin Inhibits Allergic Responses in Mice by Suppressing CD4 + T Cell Proliferation. Antioxidants (Basel) 2021; 10:antiox10071120. [PMID: 34356353 PMCID: PMC8301087 DOI: 10.3390/antiox10071120] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 07/05/2021] [Accepted: 07/09/2021] [Indexed: 02/06/2023] Open
Abstract
Allergic diseases, including atopic dermatitis (AD), induce type 2 helper T (Th2) cell-dominant immune responses. Miquelianin (quercetin 3-O-glucuronide, MQL) is an active compound in Rosae multiflorae fructus extract with anti-allergic properties. Here, we investigate the anti-allergic effects of MQL in an ovalbumin (OVA)-induced Th2-dominant mouse model and the associated mechanisms. Oral MQL suppressed cytokine and IL-2 production and proliferation of Th2 cells and upregulated heme oxygenase-1 (HO-1) in splenocytes. Ex vivo MQL suppressed Th1- and Th2-related immune responses by inhibiting CD4+ T cell proliferation, and upregulated HO-1 in CD4+ T cells by activating C-Raf-ERK1/2-Nrf2 pathway via induction of reactive oxygen species generation. In a trimellitic anhydride-induced AD-like mouse model, both topical and oral MQL ameliorated AD symptoms by suppressing Th2 immune responses. Our results suggest that MQL is a potential therapeutic agent for CD4+ T cell-mediated diseases, including allergic diseases.
Collapse
|